The Form 4 filing, a report of insider share activity, was filed on November 19, 2026. It covers Baiju Bhatt's sales on November 17, two days earlier.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-17 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 5 |
| Shares Transacted | 69,387 |
| Price | $69.03 |
| Total Transaction Value | $4,789,879.14 |
| Insider | |
| Ticker Symbol | HOOD |
| Company | Robinhood Markets, Inc. |
| Insider Name | Bhatt Baiju |
| Insider Title | Director |
| Sector - Industry | Financial Services - Capital Markets |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-11-19 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported with SEC transaction code S. Baiju Bhatt, a director at Robinhood Markets (HOOD), sold 69,387 shares across five transactions.
What was the average price of the transaction?
The average sale price was $69.03 per share across the five transactions. Prices for each individual sale are not available in the transaction details.
How did this transaction affect the insider's holdings?
The sales reduced the reported balance by 69,387 shares, leaving zero shares. The 100.00% figure means all shares in that reported balance before the sales were sold. Whether he held other shares is unknown, so this does not establish that he sold every share he owned.
What's the total transaction value?
The five sales had a total value of $4,789,879.14. Individual sale values are not available in the transaction details.
Are there any special circumstances around this transaction?
The transaction details include a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. Filing footnotes and plan terms are not available here. It is unclear whether the plan covered all five sales. Its start date and trading schedule are also unknown. The reference alone does not confirm that the sales met the rule's legal requirements.
For research purposes only; not investment advice.